Even though the NIA claims that more than 90 per cent of cases charge-sheeted have ended in conviction, the figure is likely misleading. To date, very few cases investigated by the NIA have resulted in a completed trial, points out former CBI joint director Navneet Rajan Wasan.
The National Security Strategy document should flag all major issues concerning security strategy and provide guidelines to concerned departments to work out suitable action plans. Since the global and regional geopolitical canvas is dynamic, the NSS document should be deliberated at length before formulation and should be reviewed periodically, recommends Commodore Venugopal Menon (retd).
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.
The PIL said the independent expert committee should be asked to submit its report within four weeks and direction be issued for action against state agencies for dereliction of duty.
Desai and members of the Uttarakhand panel met the Law Commission chairman, Justice (retired) Ritu Raj Awasthi, and members KT Sankaran, Anand Paliwal and DP Verma.
The senior officials of the health ministry apprised the minister on various improvements that have been made to make the pan India dry run glitch free, such as number of telephone operators has been increased to answer every possible query from the teams on the ground conducting the dry run.
An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covid vaccine Covovax on children aged 2 to 17 years with certain conditions, official sources said.
The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.
The top court observed that even in reserve forests, there are no concrete roads and the safari vehicles ply on forest roads.
The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
Union Health Minister Harsh Vardhan on Friday said the COVID-19 vaccination drive will be extended in the coming days and asserted that there should not be any misconceptions about the two Indian vaccines being administered in the country.
If the Personal Data Protection Bill gets passed in its present form, a new class of companies and entities could emerge. The sole job of these new entities would be to manage the consent for data usage of a user.Banks, healthcare firms and fintech companies, among others, fear that sharing non-personal data with the government may hurt business interests. Banks also fear the threat of data misuse.
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.
'There is no emergency of a third wave that we are rushing for booster doses.'
Congress leader in Lok Sabha Adhir Ranjan Chowdhury and some other MPs suspended from Parliament will not be able to attend the meetings of parliamentary committees of which they are a member or chairperson till their suspension is revoked.
'We will bring up students with an imperfect understanding of their own history and a superficial understanding of science.' 'This is not what we should be doing to future generations.'
The former chief minister also sought to distance JD-S's alliance partner Bharatiya Janata Party and Prime Minister Narendra Modi from the case, amid attacks by the ruling Congress seeking their response on the issue.
Pranab's earlier fear of Sonia relying too heavily on a coterie due to her lack of experience turned out to be unfounded. As per Pranab, Sonia had her close advisers but she did not follow anyone's advice blindly. A fascinating excerpt from Sharmistha Mukherjee's Pranab, My Father: A Daughter Remembers.
Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.
The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.
The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.
IMD Director General Mrutyunjay Mohapatra said that inducing artificial rain can only be attempted when there are clouds or moisture available.
Uttam Prakash Agarwal alleged that Citax and Braich offers were incomplete and did not include firm commitment as to the price, size, timings, confirmation from the banks about availability of the funds.
In light of the recent incidents involving scooters from prominent electric mobility brands bursting into flames, the subject of electric vehicle (EV) safety has come under the spotlight. As many as 20 electric scooters of Nashik-based Jitendra EV Tech caught fire after being loaded on a transport container. While no one has been reported injured, the company said it is conducting an investigation to find the 'root cause' of the fire.
'If rate cuts happen, bond yields will come down and investors will make mark-to-market capital gains on them.'
'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'
The National Council for Educational Research and Training (NCERT), however, said the withdrawal of anyone's association is out of question as textbooks at the school level are developed on the basis of knowledge and understanding on a given subject and at no stage, individual authorship is claimed.
The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective in comorbid conditions like diabetes, hypertension, according to protocol summary (of clinical trials) the trial was not designed to access the Fabiflu in comorbid conditions.
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.
Senior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for restricted use of Bharat Biotech's COVID-19 vaccine and asked the government to explain why mandatory protocols and verification of data has been dispensed with.
The poll panel also referred to the reported strong oral observations of the top court against it during the last hearing on the PIL on the issue, saying they have "caused irreparable damage to the reputation of this institution built over the years".
'It is really troublesome that someone in a position of power is misleading people and presumably, citizens of the country to give up data.' 'That is not a part of informed consent.'
The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.
The Supreme Court Thursday appreciated the Centre's step to grant ex gratia assistance to the kin of those who died due to COVID-19 saying it has to take judicial notice of the fact that what India has done, no other country has been able to do.
The signatories to a letter sent to NCERT Director Dinesh Saklani include Kanti Prasad Bajpai, a former Jawaharlal Nehru University professor who currently serves as the vice dean at the National University, Singapore, Pratap Bhanu Mehta, a former vice-chancellor of the Ashoka University, Rajeev Bhargava, a former director of CSDS, Niraja Gopal Jayal, a former JNU professor, Nivedita Menon, a JNU professor, Vipul Mudgal, the head of civil society watchdog Common Cause, K C Suri, a former professor at the University of Hyderabad who is now associated with the Gitam University, and Peter Ronald deSouza, a former director of the Indian Institute of Advanced Studies.
Palshikar and Yadav, who were chief advisors for the original Political Science books for classes 9 to 12, said, "While the modifications have been justified in the name of rationalisation, we fail to see any pedagogic rationale at work here. We find that the text has been mutilated beyond recognition. There are innumerable and irrational cuts and large deletions without any attempts to fill the gaps created.
Instead of only focusing on the tenure for which the best interest rate is available, investors should also focus on their own investment horizon.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances